Evidence map›Paper›PMID 35755132›Full record

ArticleRSC advances2022

Noble classical and quantum approach to model the optical properties of metallic nanoparticles to enhance the sensitivity of optoplasmonic sensors.

Alemayehu Getahun Kumela, Abebe Belay Gemta, Tamirat Abebe Desta, Alemu Kebede

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Alemayehu Getahun KumelaAdama Science and Technology University Adama Ethiopia alex.ph400@gmail.com.ORCID https://orcid.org/0000-0002-2589-6451
Abebe Belay GemtaAdama Science and Technology University Adama Ethiopia alex.ph400@gmail.com.ORCID https://orcid.org/0000-0001-5212-8397
Tamirat Abebe DestaAdama Science and Technology University Adama Ethiopia alex.ph400@gmail.com.ORCID https://orcid.org/0000-0002-2195-5741
Alemu KebedeAdama Science and Technology University Adama Ethiopia alex.ph400@gmail.com.
Adama Science and Technology University · ET

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The bright light obtained from the quantum principle has a key role in the construction of optical sensors. Yet, theoretical and experimental work highlights the challenges of overcoming the high cost and low efficiency of such sensors. Therefore, we report a metallic nanoparticle-based metasurface plasmons polariton using quantum and classical models. We have investigated the material properties, absorption cross-section, scattering cross-section, and efficiency of the classical model. By quantizing light-matter interaction, the quantum features of light - degree of squeezing, correlation, and entanglement are quantified numerically and computationally. In addition, we note the penetration depth and propagation length from a hybrid model in order to enhance the optoplasmonic sensor performance for imaging, diagnosing, and early perception of cancer cells with label-free, direct, and real-time detection. Our study findings conclude that the frequency of incident light, size, shape, and type of nanoparticles has a significant impact on the optical properties of metallic nanoparticles and the nonlinear optical properties of metallic nanoparticles are dynamic, enhancing the sensitivity of the optoplasmonic sensor. Moreover, the resulting bright light shows the systematic potential for further medical image processing.

Identifiers

PMID35755132
PMCPMC9173576
OpenAlexW4283644336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.